Liu, Zhongle
Basso, Pauline
Hossain, Saif
Liston, Sean D. http://orcid.org/0000-0002-6218-2247
Robbins, Nicole
Whitesell, Luke http://orcid.org/0000-0001-6445-5766
Noble, Suzanne M. http://orcid.org/0000-0001-9855-8448
Cowen, Leah E. http://orcid.org/0000-0001-5797-0110
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AI127375, R01AI127375)
Gouvernement du Canada | Canadian Institutes of Health Research (FDN-154288)
CIFAR Catalyst Award CP21-042
University of Toronto PRiME Initiative
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 11 July 2022
Accepted: 17 July 2023
First Online: 27 July 2023
Competing interests
: L.E.C. and L.W. are co-founders and shareholders in Bright Angel Therapeutics, a platform company for the development of novel antifungal therapeutics. L.E.C. is a Science Advisor for Kapoose Creek, a company that harnesses the therapeutic potential of fungi. All other authors declare no competing interests.